Adaptive Biotechnologies Corporation (ADPT)

NASDAQ: ADPT · IEX Real-Time Price · USD
4.90
-0.43 (-8.07%)
At close: Dec 29, 2023, 4:00 PM
4.91
+0.01 (0.20%)
After-hours: Dec 29, 2023, 7:33 PM EST

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 202220212020201920182017
Revenue
185.31154.3498.3885.0755.6638.45
Revenue Growth (YoY)
20.06%56.88%15.65%52.83%44.77%-
Cost of Revenue
57.9149.322.5322.2719.6715.68
Gross Profit
127.4105.0475.8562.83622.77
Selling, General & Admin
184.13169.97110.8968.7944.932.71
Research & Development
141.76142.34116.0770.7139.1632
Other Operating Expenses
1.71.71.71.71.72.53
Operating Expenses
327.59314.01228.67141.1985.7567.24
Operating Income
-200.19-208.97-152.82-78.39-49.76-44.48
Interest Expense / Income
4.2400000
Other Expense / Income
-4.23-1.69-6.59-9.79-3.31-1.64
Pretax Income
-200.19-207.28-146.23-68.61-46.45-42.83
Net Income
-200.19-207.28-146.23-68.61-46.45-42.83
Preferred Dividends
0000.96-0.1-0.14
Net Income Common
-200.19-207.28-146.23-69.57-46.35-42.7
Shares Outstanding (Basic)
143140131691312
Shares Outstanding (Diluted)
143140131691312
Shares Change
1.54%6.96%89.71%447.64%3.55%-
EPS (Basic)
-1.40-1.48-1.11-1.01-3.67-3.50
EPS (Diluted)
-1.40-1.48-1.11-1.01-3.67-3.50
Free Cash Flow
-200.29-254.47-168.49194.2-38.56-37.07
Free Cash Flow Per Share
-1.41-1.81-1.282.81-3.05-3.04
Gross Margin
68.75%68.06%77.10%73.82%64.67%59.22%
Operating Margin
-108.03%-135.39%-155.33%-92.15%-89.39%-115.68%
Profit Margin
-108.03%-134.30%-148.63%-81.78%-83.26%-111.05%
Free Cash Flow Margin
-108.09%-164.87%-171.26%228.28%-69.27%-96.42%
EBITDA
-167.81-186.3-134.49-60.82-40.45-37.04
EBITDA Margin
-90.56%-120.70%-136.70%-71.49%-72.66%-96.32%
Depreciation & Amortization
28.1520.9811.747.7965.8
EBIT
-195.95-207.28-146.23-68.61-46.45-42.83
EBIT Margin
-105.74%-134.30%-148.63%-80.65%-83.44%-111.40%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).